88257-21-0

Basic information

• Product Name: 17β-hydroxy-11β-[4-hydroxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one
• Synonyms: 17β-hydroxy-11β-[4-hydroxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one
• CAS NO: 88257-21-0
• Molecular Weight: 402.533
• Mol File: 88257-21-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 17β-hydroxy-11β-[4-hydroxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 17β-hydroxy-11β-[4-hydroxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one(88257-21-0)
• EPA Substance Registry System: 17β-hydroxy-11β-[4-hydroxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one(88257-21-0)

Safety Data

• Hazardous Substances Data: 88257-21-0(Hazardous Substances Data)

Upstream product

• 84371-57-3 (5'R,8'S,10'R,13'S,14'S,17'S)-13'-methyl-17'-(prop-1-yn-1-yl)-1',2',7',8',12',13',14',15',16',17'-decahydro-4'H,6'H-spiro[[1,3]dioxolane-2,3'-[5,10]epoxycyclopenta[a]phenanthren]-17'-ol 
• 5571-36-8 ethylene deltenone 
• 84371-69-7 (8S,13S,14S,17S)-13-methyl-17-(prop-1-yn-1-yl)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol 
• 934415-53-9 C₃₄H₄₄O₆ 

Downstream Products

• 88256-77-3 17β-hydroxy-11β-[4-methoxyphenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one 
• 1129547-71-2 17β-hydroxy-11β-[4-(9-bromnonoxy)-phenyl]-17α-(1-propinyl)-estra-4,9-dien-3-one 
• 167846-17-5 trifluoro-methanesulfonic acid 4-(17-hydroxy-13-methyl-3-oxo-17-prop-1-ynyl-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-11-yl)-phenyl ester 

Relevant articles and documents

Syntheses and antigestagenic activity of mifepristone derivatives

A series of mifepristone derivatives with different "linker groups" in position 4' of the phenyl ring in the 11β- position of the steroid scaffold (2-41) have been synthesized. Their antigestagenic activites were determined in a cell-based assay (alkali p

11-PHOSPHOROUS STEROID DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS

The present invention is directed to novel 11-phosphorous steroid derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by a progesterone or glucocorticoid receptor.